Company Profile
ClearPoint Neuro Stock Price, News & Analysis
- Ticker:
- CLPT
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
13.39 USD (+1.75%)
Close
Last updated: August 6, 2026
371M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, CLPT closed up 1.75% at $13.39. No new same-company headline was identified in the current news window.
Company overview
Brain and Spine Navigation Company
ClearPoint Neuro provides devices and services for precise navigation and therapy delivery to the brain and spine.
ClearPoint Navigation
The company’s MRI-guided platform supports stereotactic procedures including biopsy, laser ablation, deep-brain interventions, and targeted delivery of biologics.
Cell and Gene Therapy Enablement
ClearPoint works with biopharmaceutical partners on preclinical and clinical delivery of cell and gene therapies directly into the central nervous system.
Neurocritical Care Expansion
The acquisition of IRRAS added the IRRAflow active fluid-exchange system, extending the portfolio into management of intracranial bleeding and neurocritical care.
Future catalysts
The cleaner way to frame ClearPoint Neuro right now is around MRI-guidance in and spine, today announced financial results for. The most useful line from the latest update is Continued clinical trial and regulatory progress across more than 60 active biopharma partners. That should keep the program at the center of the company narrative for now. The partnership angle also matters here, especially around Received Medical Device License (MDL) from Health Canada for the ClearPoint Neuro Navigation System, covering both MRI-guidance and iCT guidance workflows with first cases now....
Recent news
- 01
ClearPoint Neuro Reports Second Quarter 2026 Results
Source: ClearPoint Neuro
- 02
- 03
ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026
Source: ClearPoint Neuro
- 04
- 05
ClearPoint Neuro Reports First Quarter 2026 Results
Source: ClearPoint Neuro
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of ClearPoint Neuro (CLPT)?
ClearPoint Neuro (CLPT) most recently closed at 13.39 USD, a +1.75% move versus the previous session.
What is the market cap of ClearPoint Neuro (CLPT)?
ClearPoint Neuro currently has a market capitalization of 371M USD on BioPharmSignal.
What does ClearPoint Neuro do?
Brain and Spine Navigation Company ClearPoint Neuro provides devices and services for precise navigation and therapy delivery to the brain and spine. ClearPoint Navigation The company’s MRI-guided platform supports stereotactic procedures including biopsy, laser ablation, deep-brain interventions, and targeted delivery of biologics. Cell and Gene Therapy...
On which exchange is CLPT stock listed?
ClearPoint Neuro (CLPT) is associated with NASDAQ, United States, Biopharma.
What is Brain?
Brain and Spine Navigation Company ClearPoint Neuro provides devices and services for precise navigation and therapy delivery to the brain and spine.
Which conditions is ClearPoint Neuro targeting with Brain?
Brain and Spine Navigation Company ClearPoint Neuro provides devices and services for precise navigation and therapy delivery to the brain and spine. ClearPoint Navigation The company’s MRI-guided platform supports stereotactic procedures including biopsy, laser ablation, deep-brain interventions, and targeted delivery of biologics. Cell and Gene Therapy...
How does ClearPoint Neuro describe recent progress with Brain?
The cleaner way to frame ClearPoint Neuro right now is around MRI-guidance in and spine, today announced financial results for. The most useful line from the latest update is Continued clinical trial and regulatory progress across more than 60 active biopharma partners. That should keep the program at the center of the company narrative for now. The...
What is Spine?
Brain and Spine Navigation Company ClearPoint Neuro provides devices and services for precise navigation and therapy delivery to the brain and spine.